Article ID | Journal | Published Year | Pages | File Type |
---|---|---|---|---|
2850386 | American Heart Journal | 2011 | 11 Pages |
Abstract
When used in primary prevention among individuals with low-density lipoprotein <130 mg/dL and high-sensitivity C-reactive protein â¥2 mg/L, rosuvastatin significantly reduced first MI, stroke, arterial revascularization, hospitalization for unstable angina, and cardiovascular death among whites and nonwhites.
Related Topics
Health Sciences
Medicine and Dentistry
Cardiology and Cardiovascular Medicine
Authors
Michelle A. MD, MPH, Robert J. ScD, PhD, Francisco A.H. MD, Alberto J. MD, Keith C. MD, Jean G. BA, Paul M MD, MPH,